InflaRx
Price & Volume
Stats
See more52W Range | $0.71-$2.81 |
Market Cap | $83.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $162,827 |
Revenue Growth (YoY) | 520.3% |
Gross Profit (12 Mos) | -$4.9M |
Diluted EPS | -$0.84 |
News
See moreYahoo Finance • 2 days ago
InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
Yahoo Finance • 19 days ago
InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
Yahoo Finance • 2 months ago
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
About
CEO | Dr. Niels C. Riedemann M.D., Ph.D. |
Address | Winzerlaer Str. 2, Jena, Germany, 07745 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 74 |
